Postmenopausal Women with Breast, Endometrial, and Ovarian Cancers Have an Increased Risk for Cardiovascular Conditions prior to Active Endocrine Therapy
Table 4
Comparison of cardiovascular diseases and cardiovascular risk factors between dyslipidemia and without dyslipidemia groups.
Variables
Total
Breast cancer
Endometrial cancer
Ovarian cancer
Dyslipidemia
Without dyslipidemia
Dyslipidemia
Without dyslipidemia
Dyslipidemia
Without dyslipidemia
Dyslipidemia
Without dyslipidemia
Age (years)
&
§
Smoking, (%)
57 (0.8)
38 (1.0)
41 (0.8)
27 (0.9)
7 (0.8)
5 (1.1)
9 (1.0)
6 (1.3)
Drinking, (%)
28 (0.4)
16 (0.4)
21 (0.4)
15 (0.5)
4 (0.4)
1 (0.2)
3 (0.3)
0 (0.0)
SBP (mmHg)
&
£
§
DBP (mmHg)
&
£
§
HTN, (%)
1195 (17.7)
572 (14.3)&
760 (15.5)
389 (12.6)
245 (26.7)
96 (21.1)£
190 (20.6)
87 (19.6)
CHD, (%)
322 (4.8)
160 (4.0)&
246 (5.0)
129 (4.2)
35 (3.8)
15 (3.3)£
41 (4.4)
16 (3.6)§
HF, (%)
95 (1.4)
34 (0.9)&
68 (1.4)
26 (0.8)
8 (0.9)
4 (0.9)
19 (2.1)
4 (0.9)§
AF, (%)
75 (1.1)
42 (1.1)
55 (1.1)
32 (1.0)
8 (0.9)
4 (0.9)
15 (1.6)
8 (1.8)
DM, (%)
631 (9.4)
296 (7.4)&
412 (8.4)
210 (6.8)
131 (14.3)
53 (11.6)£
88 (9.5)
33 (7.4)§
Stroke, (%)
160 (2.4)
66 (1.7)&
122 (2.5)
60 (1.9)
12 (1.3)
2 (0.4)£
26 (2.8)
4 (0.9)§
Glu (mmol/L)
&
£
§
SUA (μmol/L)
&
£
Creatinine (μmol/L)
&
&, , £, and § mean among total and different cancers when compared to the group with dyslipidemia and without dyslipidemia. AF: atrial fibrillation; CHD: coronary heart disease; DM: diabetes mellitus; DBP: diastolic blood pressure; FPG: fasting plasma glucose; HF: heart failure; HTN: hypertension; SBP: systolic blood pressure; SUA: serum uric acid.
